Last updated: 19 August 2024 at 9:06pm EST

Jack Higgins Net Worth




The estimated Net Worth of Jack Higgins is at least $282 Thousand dollars as of 15 August 2024. Jack Higgins owns over 19,524 units of Immunome stock worth over $282,317 and over the last few years Jack sold IMNM stock worth over $0.

Jack Higgins IMNM stock SEC Form 4 insiders trading

Jack has made over 1 trades of the Immunome stock since 2024, according to the Form 4 filled with the SEC. Most recently Jack exercised 19,524 units of IMNM stock worth $26,357 on 15 August 2024.

The largest trade Jack's ever made was exercising 19,524 units of Immunome stock on 15 August 2024 worth over $26,357. On average, Jack trades about 6,508 units every 0 days since 2023. As of 15 August 2024 Jack still owns at least 19,524 units of Immunome stock.

You can see the complete history of Jack Higgins stock trades at the bottom of the page.



What's Jack Higgins's mailing address?

Jack's mailing address filed with the SEC is C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011.

Insiders trading at Immunome

Over the last 4 years, insiders at Immunome have traded over $0 worth of Immunome stock and bought 480,004 units worth $5,722,735 . The most active insiders traders include Clay B Siegall, Jean Jacques Bienaime, and Michael Rapp. On average, Immunome executives and independent directors trade stock every 84 days with the average trade being worth of $518,362. The most recent stock trade was executed by Jean Jacques Bienaime on 15 August 2024, trading 7,000 units of IMNM stock currently worth $97,580.



What does Immunome do?

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.



What does Immunome's logo look like?

Immunome, Inc. logo

Complete history of Jack Higgins stock trades at Immunome

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
15 Aug 2024 Jack Higgins
Chief Scientific Officer
Option 19,524 $1.35 $26,357
15 Aug 2024
19,524


Immunome executives and stock owners

Immunome executives and other stock owners filed with the SEC include: